Aerolase Neo Elite
Nd:YAG laser (microsecond) · 1064nm 650-microsecond, higher energy
Classification & configurations
Category group: Hair removal (diode, alexandrite, Nd:YAG, IPL)
At a glance
- New price
- $65k–$90kSource not documented
- Used asking price
- $35k–$55kSource not documented
- FDA status
- Supplies & recurring costs
- See supply and replacement costs below.
Sources and verified data on file
Data on file
- Recurring consumables
- Not verified
- FDA
- FDA ClearedK120235
- Used asking prices
- Not verified
- This panel shows a per-treatment supply cost only when a recorded figure has a dated source.
- Bottle prices and estimates may still appear under Treatment & running costs.
- The calculator may include a labeled planning estimate. Review it or enter your own allowance; missing data never means $0.
Figures are reference points, not current offers. Used asking prices are not completed-sale values.
Read FDA-cleared indicationsExact wording from 1 FDA record
K120235 (Aerolase Medical Lasers, LLC, 2012)
The Aerolase Nd:YAG Laser is intended for use in the medical specialties of general and plastic surgery, dermatology, endoscopic/laparoscopic general surgery, gastroenterology, gynecology, otolaryngology (ENT), neurosurgery, oculoplastics, orthopedics, pulmonary/thoracic surgery, podiatry, and urology for surgical and aesthetic applications. Dermatology: The Aerolase Nd:YAG Laser is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangiectasia, rosacea, venus lake, leg veins, spider veins and poikiloderma of civatte: and treatment of benign cutaneous lesions, such as warts, scars, striae, debridement of decubitus ulcer, treatment of keloids, and psoriasis. The laser is also intended for the treatment of benign pigmented lesions such as, but not limited to, Ic(r;,73,J 7 4 lentigos (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic keratoses. nevi, chloasma, verrucae, skin tags, keratoses, tattoos (significant reduction in the intensity of black and/or blue/black tattoos) and plaques. Additionally, the Aerolase Nd:YAG Laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. The Aerolase Nd:YAG Laser is also indicated for the treatment of wrinkles, such as, but not limited to, periocular and perioral wrinkles. The Aerolase Nd:YAG Laser is also indicated for the reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. The Aerolase Nd:YAG Laser is also indicated for treatment of mild to moderate inflammatory acne vulgaris. The Aerolase Nd:YAG Laser is also indicated for the removal of unwanted hair, for stable long-term, or permanent, hair reduction through selective targeting of melanin in hair follicles, and for the treatment for pseudofolliculitis barbae (PFB). Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The Aerolase Nd:YAG Laser is indicated for use on all skin types (Fitzpatrick I-VI), including tanned skin.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Page updated: September 8, 2026 · How we verify
Axis runs $0–$90k. Reference figures, not current offers. Used asking prices are not completed-sale values.
Not verified
We hold no per-treatment consumable price for this device from a dated source. Ask the seller for a written per-treatment cost.
Price sourcesSources, dates and configurations
Key factsCompany, specifications and verification dates
| Manufacturer | Aerolase |
|---|---|
| Company | Ownership: not yet verified. |
| Parent company | Aerolase |
| Brand owner | Aerolase |
| Built by (OEM) | Aerolase Corp. |
| Category | Nd:YAG laser (microsecond) |
| Technology | 1064nm 650-microsecond, higher energy |
| FDA status | FDA Cleared |
| 510(k) citation | K120235 |
| New price range | $65k–$90k |
| Used asking range | $35k–$55k |
| Consumables | Not published |
| Launch year | 2018 |
| Pricing | Not published |
| Manufacturer-source documents checked | Not published |
Overview
Pain-tolerant all-skin-type HR/skin device
How it worksTechnology and manufacturing
How the technology works
Single-wavelength 1064nm Nd:YAG delivering energy in a 650-microsecond pulse — shorter than the thermal relaxation time of melanin-rich epidermis, so heat deposits in targets (hemoglobin, melanin, sebaceous activity, water) before it can diffuse and injure surrounding skin.
That's why it runs without contact cooling, gel, or chillers and stays safe on Fitzpatrick IV-VI. Used for inflammatory acne (NeoClear), rosacea and redness, PIH and benign pigment, hair reduction, PFB, onychomycosis, warts, and NeoSkin revitalization passes.
Patented technology
"650 Microsecond Technology" — a proprietary compact laser head firing unusually short free-running Nd:YAG pulses at high peak power; the pulse duration, not a new wavelength, is the entire differentiator.
Origin
USA (Tarrytown, New York).
FDA & regulatory detailClearance timeline, authorization route and citation notes
Clearance 2012 · Launch 2018 · K120235
Family clearance: K120235 (model family of Aerolase Nd:YAG lasers — FriendlyLight Neo, LightPod Neo and LightPod Nd:YAG lasers, decision 17 Sep 2012). FDA's device listing carries the LightPod Neo and Neo Elite together under the same listing. Checked 8 Sep 2026.
FDA-cleared indications (verbatim)
K120235 (Aerolase Medical Lasers, LLC, 2012)
The Aerolase Nd:YAG Laser is intended for use in the medical specialties of general and plastic surgery, dermatology, endoscopic/laparoscopic general surgery, gastroenterology, gynecology, otolaryngology (ENT), neurosurgery, oculoplastics, orthopedics, pulmonary/thoracic surgery, podiatry, and urology for surgical and aesthetic applications. Dermatology: The Aerolase Nd:YAG Laser is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangiectasia, rosacea, venus lake, leg veins, spider veins and poikiloderma of civatte: and treatment of benign cutaneous lesions, such as warts, scars, striae, debridement of decubitus ulcer, treatment of keloids, and psoriasis. The laser is also intended for the treatment of benign pigmented lesions such as, but not limited to, Ic(r;,73,J 7 4 lentigos (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic keratoses. nevi, chloasma, verrucae, skin tags, keratoses, tattoos (significant reduction in the intensity of black and/or blue/black tattoos) and plaques. Additionally, the Aerolase Nd:YAG Laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. The Aerolase Nd:YAG Laser is also indicated for the treatment of wrinkles, such as, but not limited to, periocular and perioral wrinkles. The Aerolase Nd:YAG Laser is also indicated for the reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. The Aerolase Nd:YAG Laser is also indicated for treatment of mild to moderate inflammatory acne vulgaris. The Aerolase Nd:YAG Laser is also indicated for the removal of unwanted hair, for stable long-term, or permanent, hair reduction through selective targeting of melanin in hair follicles, and for the treatment for pseudofolliculitis barbae (PFB). Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The Aerolase Nd:YAG Laser is indicated for use on all skin types (Fitzpatrick I-VI), including tanned skin.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Marketed for
Nd:YAG laser (microsecond) — 1064nm 650-microsecond, higher energy
Marketing claims are the manufacturer's own and are not the same as a cleared indication.
Parent company: Aerolase
Legal manufacturer: Aerolase Corp. (United States)
Applicant on the FDA record
Aerolase Medical Lasers, LLCThe applicant named on the FDA record can differ from the brand shown on the device.
Regulatory data comes from public FDA records and may lag recent updates. Confirm the applicable status and documentation before purchase.
Treatment & running costs
Treatments
Sessions & timing
No treatment schedule documented yet.
What practices charge
No sourced treatment price on file.
Supplies & recurring costs
Effectively zero — no tips, no gel, no cryogen, air-cooled. A few hundred dollars a year in distance gauges and optics.
Annual service & support
No annual service cost documented yet.
Payback calculatorModel your own volume, labor and service costs
Estimate your payback
Pre-filled from our published Aerolase Neo Elite data where we have it. Estimates appear once the required inputs are available. Review and adjust every pre-filled value before relying on the result.
Start from
No verified per-treatment supply cost is on file. Enter your own allowance. Use $0 only if you have confirmed that it applies to your practice.
Pre-filled from the midpoint of the published new-price range
20 is an illustrative default — change it to your volume.
No sourced per-session price on file — enter what you charge.
Required — enter your cost; missing data does not mean $0.
Provider or tech time for one treatment, fully loaded. Enter 0 if you own-operate.
Annual service contract ÷ 12, if you carry one.
Your estimate
Enter price you charge per treatment, consumable cost per treatment to see contribution and a payback range.
This model ignores financing — if you lease or borrow, add your monthly payment. Estimates from your inputs and our published ranges — not a projection, guarantee or financial advice. How we calculate this.
ComplianceScreening and contraindications on the manufacturer's record
Contraindications & screening
Pregnancy, recent isotretinoin (policy varies), photosensitizers, active infection or open lesions, recent significant tanning, gold therapy, unrealistic melasma expectations.
Warranty & serviceWhat to confirm in writing before you buy
Before buying new or used, confirm in writing:
- Current warranty coverage
- Included training
- Service terms
Chains using this device
A chain listing does not establish availability at every location.
No confirmed chain deployments recorded yet.
Owner & operator reviews
Write a reviewNo owner or operator reviews yet. Be the first →
Current alternatives
Current catalog models to research. Confirm availability and configuration with the supplier.
No current alternatives identified in the catalog yet. Browse current models
History5 tracked changes
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
September 8, 2026
FDA status
Unknown → Cleared
Source: Record correction
September 8, 2026
FDA K-numbers
K120235
Source: Record correction
September 8, 2026
FDA source URL
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K120235
Source: Record correction
September 8, 2026
consumables detail
Catalog update — superlatives, margin judgements and unsourced dollar claims removed (neutral-voice standard, 8 Sep 2026)
Source: Editorial standard
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Cite this data: The Aesthetic Index, "Aerolase Neo Elite — pricing, FDA status and cost to own", aestheticindex.co (accessed September 24, 2026).
Get the full State of Aesthetic Devices 2026 report
A catalog of US-marketed aesthetic and wellness devices — preview it free.
Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.